Live Breaking News & Updates on Sierra Oncology|Page 12

Stay updated with breaking news from Sierra oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Phase 3 Trial: Maribavir Yields Post-Transplant Benefits

Maribavir may reduce mortality risk among patients with resistant or refractory post-transplant CMV infection following hematopoietic stem cell and solid organ transplant. ....

Israel General , United States , Comunidad Autonoma De Cataluna , Maria Laura Fox , Ishan Hirji , Drug Administration , Bristol Myers Squibb , Hebron Institute Of Oncology , Takeda Development Center Americas , European Society For Bone , European Society , Hebron Institute , Sierra Oncology , Transplantation Stem Cell , Ransplantation Hematopoietic Stem Cell , Hematopoietic Stem Cell Transplantation , Stem Cell Transplantation , Stem Cell Therapy , Herapy Stem Cell , Cytomegalovirus Cmv , Cytomegalovirus Infection , Transplantation Organ , Organ Transplantation , Transplant Center , Acute Leukemia ,

Glaxo on the hunt for more takeover targets

On a call discussing first quarter results, chief exec Emma Walmsley (pictured) said the firm had more in the hopper as it scoped out new takeover targets. ....

Emma Walmsley , Bellus Health , Sierra Oncology ,

GSK surpasses expectations thanks to rising sales of shingles vaccine

The pharmaceutical giant revealed turnover fell by 8 per cent at constant exchange rates to £6.95billion in the opening three months of 2023. ....

City Of , United Kingdom , Phil Dormitzer , Toro Adam Vettese , Bellus Health , Drug Administration , Respiratory Syncytial , Sierra Oncology ,

GSK beats first-quarter profit, revenue estimates

GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines. ....

City Of , United Kingdom , Natalie Grover , Maggie Fick , Thomson Reuters Trust Principles , Bellus Health , Sierra Oncology , Thomson Reuters Trust , Rsbi Shareholder Activism , Rsbi Regulatory Oversight , Rhpi Corporate Structure , Rhpi Commercial Strategy , Rhpi Drug Device Trials , Rhpi Regulatory , Rhpi Public Health , Sustainable Business ,

GSK sales fall after demand for Covid treatment plummets

Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators ....

City Of , United Kingdom , Emma Walmsley , Bellus Health , Financial Times , Sierra Oncology , Covid 19 ,